MedTrace Logo

Lumenato Nutritional Supplement on Skin Appearance

NCT04248699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-08-18

No results posted yet for this study

Summary

This 12-week study is an open-label study assessing the perceived effectiveness of the Lycored Lumenato supplement on skin health and appearance.

Conditions

  • Skin

Interventions

DIETARY_SUPPLEMENT

Lumenato

tomato oleoresin obtained from yellow dry tomato pulp

Sponsors & Collaborators

  • ObvioHealth

    collaborator INDUSTRY

  • LycoRed Ltd.

    lead INDUSTRY

Principal Investigators

  • Parth Shah, MD · ObvioHealth

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-14
Primary Completion
2020-06-08
Completion
2020-07-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248699 on ClinicalTrials.gov